Parnell Pharmaceuticals Holdings Ltd Stock OTC Bulletin Board
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2020 | 30M 19.96M 27.17M | Sales 2021 | 34.17M 22.73M 30.94M | Capitalization | 4.08K 2.72K 3.7K |
---|---|---|---|---|---|
Net income 2020 | -15M -9.98M -13.59M | Net income 2021 | -1M -665K -906K | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 37.36M 50.86M | Net Debt 2021 | 58.89M 39.18M 53.34M | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 10-01-31 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 20-12-20 |
1st Jan change | Capi. | |
---|---|---|
-14.09% | 77.37B | |
+18.66% | 8.74B | |
+23.75% | 3.67B | |
-0.42% | 3.25B | |
+18.07% | 1.73B | |
-16.99% | 1.38B | |
-26.05% | 1.24B | |
-17.86% | 1.07B | |
-6.77% | 976M |